Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
EnteroMedics plans secondary offering
You may also be interested in...
People In Brief
ResMed, Tornier, CombiMatrix welcome new CEOs; Greg S. Lea becomes COO at EnteroMedics; more people briefs.
New Products In Brief
Bausch & Lomb's Stellaris PC: Company debuts its Stellaris PC (Procedural Choice) vision enhancement system overseas following CE mark approval last May. The combined vitrectomy and phacoemulsification system, for which a May 510(k) submission remains pending at FDA, enhances surgeons' ability to see ocular tissue under various surgical conditions, B&L claims. Stellaris PC is indicated for emulsification and removal of cataracts, and anterior and posterior segment vitrectomy
Research In Brief
Physician conflict-of-interest disclosure: About 79% of physicians self-reported conflicts of interest for payments directly related to presentations at the 2008 American Academy of Orthopedic Surgeons annual meeting, according to an article published in the Oct. 8 New England Journal of Medicine. The study, led by Kanu Okike, Brigham and Women's Hospital/Massachusetts General Hospital, found that the overall disclosure rate was 71.2%. For payments indirectly related to an AAOS presentation, the rate was 50%. According to a multivariate analysis, it was more likely for a payment to be disclosed if it exceeded $10,000, was directed toward an individual doctor or included an in-kind component. The study was based on physician payments disclosed on the Web sites of Biomet, Johnson & Johnson/DePuy, Stryker, Smith & Nephew and Zimmer. The five companies were required to make physician payments public as part of a 2007 settlement with the Department of Justice (1"The Gray Sheet" Oct. 1, 2007)